tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Compare Capricor Therapeutics (CAPR) vs. Competitors

Compare
1,256 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Capricor Therapeutics
$24.50
$1.33B
-13.62
62.57%
8 Buy
0 Hold
0 Sell
Strong Buy
Galectin Therapeutics
$5.71
$190.86M
-5.01
136.80%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alector
$1.93
$210.66M
-1.80
12.87%
1 Buy
2 Hold
2 Sell
Hold
4D Molecular Therapeutics
$9.29
$473.86M
-2.36
56.93%
6 Buy
1 Hold
0 Sell
Strong Buy
Humacyte
$0.96
$184.93M
-78.08%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CAPR
Capricor Therapeutics
24.50
10.17
70.97%
GALT
Galectin Therapeutics
2.96
1.64
124.24%
ALEC
Alector
1.93
0.14
7.82%
IMAB
FDMT
4D Molecular Therapeutics
9.29
2.77
42.48%
HUMA
Humacyte
0.96
-3.31
-77.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts